Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Malondialdehyde polyclonal antibody

 
ALX-210-879-R100 100 µl 583.00 USD
Do you need bulk/larger quantities?
 

Product Specification

Alternative Name:MDA
 
Host:Rabbit
 
Immunogen:Malondialdehyde (MDA) conjugated to KLH.
 
Species reactivity:Species independent
 
Specificity:Recognizes MDA adducts.
 
Applications:ELISA, IHC, WB
 
Recommended Dilutions/Conditions:ELISA (1:1,000-1:10,000)
Immunohistochemistry (1:500-1:1,000)
Western blot (1:500-1:1,000)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
 
Purity Detail:Unpurified
 
Formulation:Liquid. Contains 0.05% sodium azide. Reconstituted with 100μl water.
 
Use/Stability:Do not freeze, thaw or store diluted working solutions.
 
Handling:Avoid freeze/thaw cycles. After opening, prepare aliquots and store at -20°C.
 
Shipping:Shipped on Blue Ice
 
Long Term Storage:-20°C
 
Scientific Background:MDA (Malondialdehyde) is a highly reactive three carbon dialdehyde produced as a byproduct of polyunsaturated fatty acid peroxidation and arachidonic acid metabolism. MDA readily combines with several functional groups on molecules including proteins, lipoproteins, and DNA. MDA modified proteins may show altered physico-chemical behavior and antigenicity. Antibodies to MDA will help to visualize the MDA-adducts.
 

Product Literature References

Epigallocatechin-3-gallate protects against hepatic ischaemia-reperfusion injury by reducing oxidative stress and apoptotic cell death: E. Tak, et al.; J. Int. Med. Res. (2016), Application(s): Western blot, Abstract; Full Text
Glomerular malondialdehyde levels in patients with focal and segmental glomerulosclerosis and minimal change disease: S.T. Nezhad, et al.; Saudi J. Kidney Dis.Transpl. 21, 886 (2010), Abstract; Full Text
Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury.: M. Penkowa, et al.; Exp. Neurol. 181, 130 (2003), Abstract;
Role of metallothionein-III following central nervous system damage.: J. Carrasco, et al.; Neurobiol. Dis. 13, 22 (2003), Abstract;
Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitis.: M. Penkowa, et al.; J. Neuroimmunol. 119, 248 (2001), Abstract;
Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures.: M. Penkowa, et al.; Neuroscience 102, 805 (2001), Abstract;
Enhanced seizures and hippocampal neurodegeneration following kainic acid-induced seizures in metallothionein-I + II-deficient mice.: J. Carrasco, et al.; Eur. J. Neurosci. 12, 2311 (2000), Abstract;

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
Malondialdehyde
By biological activity:
Malondialdehyde Polyclonal antibody
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Related Literature

Brochures
Comprehensive Tools for Quantifying Cellular Responses to Oxidative Damage
Comprehensive Tools for Quantifying Cellular Responses to Oxidative Damage
Download as PDF

Technical Posters
Disease-Associated Stress Signaling
Disease-Associated Stress Signaling
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,